Riken Vitamin Co. Ltd. said its normalized net income for the fiscal first quarter ended June 30 was ¥33.18 per share, a decrease of 20.8% from ¥41.92 per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥733.8 million, a decrease of 20.8% from ¥926.9 million in the year-earlier period.
The normalized profit margin fell to 3.7% from 4.6% in the year-earlier period.
Total revenue totaled ¥20.05 billion, compared with ¥20.14 billion in the year-earlier period, and total operating expenses came to ¥18.93 billion, compared with ¥18.84 billion in the prior-year period.
Reported net income decreased 17.9% year over year to ¥833.0 million, or ¥37.67 per share, from ¥1.01 billion, or ¥45.86 per share.
As of Aug. 12, US$1 was equivalent to ¥102.19.